塔西利司(GDC-032)是罗氏公司开发的一种实验性癌症药物。它是一种靶向磷脂酰肌醇3-激酶亚型PIK3CA的小分子抑制剂。
-
默认
常备现货
-
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空选项
-
Ethyl 2-methyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl)propanoate
-
BD3168421201657-32-098%
-
¥4000.005g常备现货
-
9-Bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
-
BD3168741282516-67-998%
-
¥700.001g常备现货
-
5-Bromo-2-(1H-imidazol-2-yl)phenol
-
BD2625221282516-66-895%
-
¥4040.001g常备现货
-
9-Bromo-2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine
-
BD5597401282514-63-998%
-
¥15684.00250mg
-
9-Bromo-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepine-2-carboxylic acid
-
BD3168751282516-74-895+%
-
¥5803.001g
-
4-Bromo-2-fluoro-N-hydroxybenzimidamide
-
BD263929635702-31-795%
-
¥886.001g
-
Ethyl 2-(4-bromo-1H-pyrazol-1-yl)-2-methylpropanoate
-
BD5568201040377-17-098%
-
¥4615.001g
-
2-(4-(2-(1-Isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanoic acid
-
BD6347591282513-03-498%
-
¥9777.00250mg